Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1988-11-9
|
pubmed:abstractText |
The relative contributions of IL-2 and IL-4 during the immune response to the retrovirus-induced tumor, FBL, were examined. Both proliferative and cytolytic responses to FBL were measured and compared to similar responses to minor histocompatibility Ag. The addition of alpha IL-2 partially inhibited FBL-stimulated proliferation of purified L3T4+ T cells and nearly completely inhibited the response of Lyt-2+ T cells, whereas alpha IL-4 partially inhibited the proliferative response of the L3T4+ subset but had no effect on the response of the Lyt-2+ subset. The addition of exogenous IL-4 augmented the proliferative response of both subsets. Therefore, IL-4 is an endogenous growth factor for FBL-induced specific proliferation of the L3T4+ and not the Lyt-2+ population, but both subpopulations can respond to IL-4. Similar examination of anti-FBL CTL responses revealed that alpha IL-2, but not alpha IL-4, inhibited FBL-specific Lyt-2+ CTL generation. However, exogenous IL-4 partially replaced the L3T4+ Th cell activity necessary for optimal Lyt-2+ FBL-specific CTL generation. Therefore, IL-4 is not required but can participate in the CTL response. The role of IL-4 during the immune response of B6 mice to minor histocompatibility Ag disparate BALB.B cells was analyzed. alpha IL-4 had no detectable effect on the proliferative or cytolytic response to BALB.B cells, suggesting that endogenous IL-4 does not have a significant role in these responses. The extent of involvement of endogenous IL-4 in the T cell responses to retrovirus-induced tumor Ag and minor histocompatibility Ag presumably reflects the nature of the stimulating Ag, and detection of an IL-4 response may correlate with induction of an antibody response. Thus, the immunizing Ag and/or host B cell repetoire may influence which subsets of L3T4+ Th cells are activated during priming in vivo.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
141
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2824-30
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2459230-Animals,
pubmed-meshheading:2459230-Antibodies,
pubmed-meshheading:2459230-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:2459230-Cell Transformation, Viral,
pubmed-meshheading:2459230-Epitopes,
pubmed-meshheading:2459230-Female,
pubmed-meshheading:2459230-Friend murine leukemia virus,
pubmed-meshheading:2459230-Immunosuppressive Agents,
pubmed-meshheading:2459230-Interleukin-2,
pubmed-meshheading:2459230-Interleukin-4,
pubmed-meshheading:2459230-Interleukins,
pubmed-meshheading:2459230-Leukemia, Erythroblastic, Acute,
pubmed-meshheading:2459230-Lymphocyte Activation,
pubmed-meshheading:2459230-Mice,
pubmed-meshheading:2459230-Mice, Inbred BALB C,
pubmed-meshheading:2459230-Mice, Inbred C57BL,
pubmed-meshheading:2459230-Mice, Inbred CBA,
pubmed-meshheading:2459230-Spleen,
pubmed-meshheading:2459230-T-Lymphocytes, Cytotoxic
|
pubmed:year |
1988
|
pubmed:articleTitle |
Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor.
|
pubmed:affiliation |
Department of Microbiology/Immunology, University of Washington, Seattle 98195.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|